Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark Smithers

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|March 19, 2016
Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanomaCasey J Rowe, Fiona Tang, Maria Celia B Hughes, et al.
Journal of the American Academy of Dermatology|July 17, 2018
Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primaryLena A von Schuckmann, Louise F Wilson, Maria Celia B Hughes, et al.
BMC Cancer|July 22, 2015
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)Trevor Leong, B Mark Smithers, Michael Michael, et al.
Annals of Surgical Oncology|October 29, 2014
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic MelanomaJohn F Thompson, Sanjiv S Agarwala, B Mark Smithers, et al.
Journal of Surgical Oncology|March 18, 2014
Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanomaBrendon J Coventry, Hidde M Kroon, Mitchell H Giles, et al.
Pathology, Research and Practice|October 13, 2023
Prognosis of naevoid melanomasMartin G Cook, Megan Grant, Yvonne Sylvestre, et al.
The Australasian Journal of Dermatology|November 11, 2011
Dermoscopic naevus patterns in people at high versus moderate/low melanoma risk in QueenslandNicola C Douglas, Theo Borgovan, Melissa J Carroll, et al.
The Lancet. Oncology|September 1, 2005
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trialBryan H Burmeister, B Mark Smithers, Val Gebski, et al.
Journal of Surgical Oncology|May 29, 2018
Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagusEls Visser, David Edholm, B Mark Smithers, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2014
Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomyKiarash Khosrotehrani, Augustinus P T van der Ploeg, Victor Siskind, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|March 19, 2016
Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanomaCasey J Rowe, Fiona Tang, Maria Celia B Hughes, et al.
Journal of the American Academy of Dermatology|July 17, 2018
Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primaryLena A von Schuckmann, Louise F Wilson, Maria Celia B Hughes, et al.
BMC Cancer|July 22, 2015
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)Trevor Leong, B Mark Smithers, Michael Michael, et al.
Annals of Surgical Oncology|October 29, 2014
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic MelanomaJohn F Thompson, Sanjiv S Agarwala, B Mark Smithers, et al.
Journal of Surgical Oncology|March 18, 2014
Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanomaBrendon J Coventry, Hidde M Kroon, Mitchell H Giles, et al.
Pathology, Research and Practice|October 13, 2023
Prognosis of naevoid melanomasMartin G Cook, Megan Grant, Yvonne Sylvestre, et al.
The Australasian Journal of Dermatology|November 11, 2011
Dermoscopic naevus patterns in people at high versus moderate/low melanoma risk in QueenslandNicola C Douglas, Theo Borgovan, Melissa J Carroll, et al.
The Lancet. Oncology|September 1, 2005
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trialBryan H Burmeister, B Mark Smithers, Val Gebski, et al.
Journal of Surgical Oncology|May 29, 2018
Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagusEls Visser, David Edholm, B Mark Smithers, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2014
Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomyKiarash Khosrotehrani, Augustinus P T van der Ploeg, Victor Siskind, et al.
Pageof 13